Iambic Therapeutics Statistics
Total Valuation
IAM has a market cap or net worth of $729.26 million. The enterprise value is $526.61 million.
| Market Cap | 729.26M |
| Enterprise Value | 526.61M |
Important Dates
The next estimated earnings date is Monday, November 23, 2026, after market close.
| Earnings Date | Nov 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
IAM has 47.40 million shares outstanding.
| Current Share Class | 47.40M |
| Shares Outstanding | 47.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.41% |
| Owned by Institutions (%) | 3.07% |
| Float | 11.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 39.96 |
| Forward PS | 12.48 |
| PB Ratio | 4.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 28.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.59 |
| Quick Ratio | 4.51 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7,706.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -53.13% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $106,731 |
| Profits Per Employee | -$551,146 |
| Employee Count | 171 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IAM has paid $47,000 in taxes.
| Income Tax | 47,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.28 |
| Average Volume (20 Days) | 833,269 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IAM had revenue of $18.25 million and -$94.25 million in losses. Loss per share was -$4.27.
| Revenue | 18.25M |
| Gross Profit | -83.49M |
| Operating Income | -100.19M |
| Pretax Income | -94.20M |
| Net Income | -94.25M |
| EBITDA | -98.81M |
| EBIT | -100.19M |
| Loss Per Share | -$4.27 |
Balance Sheet
The company has $207.88 million in cash and $5.23 million in debt, with a net cash position of $202.65 million or $4.28 per share.
| Cash & Cash Equivalents | 207.88M |
| Total Debt | 5.23M |
| Net Cash | 202.65M |
| Net Cash Per Share | $4.28 |
| Equity (Book Value) | 161.48M |
| Book Value Per Share | -9.85 |
| Working Capital | 174.77M |
Cash Flow
In the last 12 months, operating cash flow was -$65.73 million and capital expenditures -$2.44 million, giving a free cash flow of -$68.17 million.
| Operating Cash Flow | -65.73M |
| Capital Expenditures | -2.44M |
| Depreciation & Amortization | 1.38M |
| Net Borrowing | -98,000 |
| Free Cash Flow | -68.17M |
| FCF Per Share | -$1.44 |
Margins
| Gross Margin | n/a |
| Operating Margin | -548.93% |
| Pretax Margin | -516.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IAM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -27.76% |
| FCF Yield | -9.35% |
Analyst Forecast
The average price target for IAM is $27.25, which is 77.12% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.25 |
| Price Target Difference | 77.12% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 131.21% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IAM has an Altman Z-Score of -1.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.88 |
| Piotroski F-Score | 1 |